Skip to content

Tonsillectomy vs. Tonsillotomy in Adults With Obstructive Sleep Apnea

Tonsillectomy Versus Tonsillotomy in Adults With Obstructive Sleep Apnea; a Randomized Controlled Trial Comparing Postoperative Morbidity

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06376383
Enrollment
464
Registered
2024-04-19
Start date
2025-01-31
Completion date
2027-09-30
Last updated
2024-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea, Tonsillar Hypertrophy

Keywords

Tonsillectomy, Obstructive sleep apnea (OSA), Tonsillotomy, Intracapsular reduction of tonsils, Drug Induced Sedation Endoscopy

Brief summary

The primary purpose of this randomized controlled trial s to investigate whether surgical reduction of palatine tonsils (tonsillotomy) is a superior treatment compared to complete surgical removal of palatine tonsils (tonsillectomy) in adults patients with obstructive sleep apnea and concomitant enlarged tonsils in regards of perioperative and postoperative morbidity.

Interventions

PROCEDURETonsillectomy

Standard tonsillectomy

PROCEDURETonsillotomy

Tonsillotomy

Sponsors

University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years * Tonsil size 2, 3, or 4 (Friedman tonsil scale) * Confirmed OSA with sleep analysis not older than a year either CRM or PSG * ASA 1 or 2 * BMI \< 35 kg/m2

Exclusion criteria

Children age \< 18 years * Previous pharyngeal surgery such as previous tonsillotomy, tonsillectomy or palatal surgery * Epileptic disease or severe neurological comorbidity. * ASA 3, or 4. * Central sleep apnea * Previous thrombotic disease. * Currently treated with sleep medications * No collapse of oropharyngeal lateral wall during DISE * Dropout of study, lack of sleep analysis or lack of postoperative DISE.

Design outcomes

Primary

MeasureTime frameDescription
Postoperative hemorrhage14 daysPostoperative hemorrhage event - readmission to the hospital
Postoperative pain30 daysPostoperative pain self-assed daily by using Visual Analoge Scale (VAS) 0 = No pain, 10 = maximal pain.
Recovery time - Sick leave30 daysSick-leave in days, measured when the patient is at work or back at school, day 0 = surgery day and outcome day is last day of sick-leave
Morbidity30 daysRe-admission at the hospital. Event is registered as null if no re-admission occurs and 1 or 2 etc. if re-admission occurs within first 30 days after surgery

Secondary

MeasureTime frameDescription
AHI180 daysApnea Hypopnea Index before and after surgery. Increase in AHI means worsening in apnea hypopnea index. AHI is measured by performing at home type 3 sleep registration
DISE - VOTE180 daysVelum Oropharyngeal Tongue base Epiglottis (VOTE) evaluation. 0 = no collaps 1. = partial collaps 2. = complete collaps

Contacts

Primary ContactKasra Zainali-Gill, Ph.D
kasrzain@rm.dk+4578439744

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026